blepharokeratoconjunctivitis

bleph·a·ro·ker·a·to·con·junc·ti·vi·tis

(blef'ă-rō-ker'ă-tō-kon-jŭnk'ti-vī'tis),
An inflammation involving the eyelids, cornea, and conjunctiva.

bleph·a·ro·ker·a·to·con·junc·ti·vi·tis

(blef'ă-rō-ker'ă-tō-kŏn-jŭngk'ti-vī'tis)
An inflammation involving the eyelids, cornea, and conjunctiva.
References in periodicals archive ?
Blepharokeratoconjunctivitis (BKC) is a chronic, inflammatory eyelid margin disease with conjunctival and corneal involvement.
Given the results and EUA findings the diagnosis was staphylococcal hypersensitivity/chronic blepharokeratoconjunctivitis (BKC) secondary to meibomianitis, with corneal neovascularization and scarring [2, 3].
Investigations for the twins with blepharokeratoconjunctivitis. Full blood count (FBC), electrolytes urea and creatinine (EUC), calcium magnesium phosphate (CMP), liver function tests (LFT), C-reactive protein (CrP), immunoglobulin M (IgM), immunoglobulin G (IgG), herpes simplex virus (HSV), varicella-zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), Treponema pallidum (TP) antibody test, tuberculosis (TB), antinuclear antibodies (ANA), anti-neutrophil cytoplasmic antibody (ANCA), erythrocyte sedimentation rate (ESR), white cell count (WCC), polymerase chain reaction (PCR), and Epstein-Barr encoding region in situ hybridization (EBER ISH).
Lopez-Rubio, "Blepharokeratoconjunctivitis in childhood: Corneal involvement and visual outcome," Eye (Basingstoke), vol.
Hammersmith, "Blepharokeratoconjunctivitis in children," Current Opinion in Ophthalmology, vol.
Nischal, "Visual Outcome and Corneal Changes in Children with Chronic Blepharokeratoconjunctivitis," Ophthalmology, vol.
Dart, "Blepharokeratoconjunctivitis in children: Diagnosis and treatment," British Journal of Ophthalmology, vol.
Cabrera, "Sub-tenon triamcinolone acetonide injections for topical medication intolerance in chronic blepharokeratoconjunctivitis," Cornea, vol.
Caption: FIGURE 1: Photographs of Twin 1 with blepharokeratoconjunctivitis before and after treatment over a 10-month period.
These patients might develop severe blepharokeratoconjunctivitis leading to peripheral corneal thinning and vascularisation (Figure 4).
[Treatment of chronic blepharokeratoconjunctivitis with local calcineurin inhibitors].